Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Leila Asfour, Ahmed Kazmi & Rodney Sinclair. (2023) An evaluation of the available pharmacotherapy for the treatment of hirsutism. Expert Opinion on Pharmacotherapy 24:7, pages 803-813.
Read now
Read now
Seemab Ashraf, Rabia Aslam, Irfan Bashir, Imtiaz Majeed & Muhammad Jamshaid. (2022) Environmental determinants and PCOS symptoms severity: a cross-sectional study. Health Care for Women International 43:1-3, pages 98-113.
Read now
Read now
Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now
Read now
Roshni Patel & Gaurang Shah. (2017) Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Current Medical Research and Opinion 33:9, pages 1545-1557.
Read now
Read now
Morena Luigia Rocca, Roberta Venturella, Rita Mocciaro, Annalisa Di Cello, Angela Sacchinelli, Valentina Russo, Simona Trapasso, Fulvio Zullo & Michele Morelli. (2015) Polycystic ovary syndrome: chemical pharmacotherapy. Expert Opinion on Pharmacotherapy 16:9, pages 1369-1393.
Read now
Read now
Antonio La Marca, Valentina Grisendi, Giulia Dondi, Giovanna Sighinolfi & Antonio Cianci. (2015) The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study. Gynecological Endocrinology 31:1, pages 52-56.
Read now
Read now
Articles from other publishers (39)
Fernando Bril, Uche Ezeh, Mina Amiri, Sana Hatoum, Lauren Pace, Yen-Hao Chen, Fred Bertrand, Barbara Gower & Ricardo Azziz. (2023) Adipose Tissue Dysfunction in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism.
Crossref
Crossref
Muhammad Sohaib Khan, Hee-Sun Kim, Ranhee Kim, Sang Ho Yoon & Sang Geon Kim. (2023) Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome. International Journal of Molecular Sciences 24:8, pages 7454.
Crossref
Crossref
Ganesh D. BarkadeSakshi A. BhongalPallavi K. DaniShrutika R. Gund. (2022) A Systematic Review: Polycystic Ovarian Syndrome (PCOS). Asian Journal of Research in Pharmaceutical Sciences, pages 309-313.
Crossref
Crossref
Mohammed A. Abdalla, Najeeb Shah, Harshal Deshmukh, Amirhossein Sahebkar, Linda Östlundh, Rami H. Al‐Rifai, Stephen L. Atkin & Thozhukat Sathyapalan. (2022) Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta‐analysis of randomized controlled trials. Clinical Endocrinology 96:6, pages 758-780.
Crossref
Crossref
Mohammed A. Abdalla, Najeeb Shah, Harshal Deshmukh, Amirhossein Sahebkar, Linda Östlundh, Rami H. Al‐Rifai, Stephen L. Atkin & Thozhukat Sathyapalan. (2021) Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta‐analysis of randomized controlled trials. Clinical Endocrinology 96:3, pages 371-394.
Crossref
Crossref
Chelsea Baker, Cimmaron Retzik-Stahr, Vatsala Singh, Renee Plomondon, Victoria Anderson & Neda Rasouli. (2021) Should metformin remain the first-line therapy for treatment of type 2 diabetes?. Therapeutic Advances in Endocrinology and Metabolism 12, pages 204201882098022.
Crossref
Crossref
Arianna Pani, Ilaria Gironi, Giacoma Di Vieste, Elena Mion, Federico Bertuzzi & Basilio Pintaudi. (2020) From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management. International Journal of Endocrinology 2020, pages 1-10.
Crossref
Crossref
Daniela Romualdi, Valeria Versace & Antonio Lanzone. (2020) What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment. Therapeutic Advances in Reproductive Health 14, pages 263349412090870.
Crossref
Crossref
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari & Giovanni Targher. (2019) NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management. International Journal of Molecular Sciences 20:11, pages 2841.
Crossref
Crossref
Charles J. Glueck & Naila Goldenberg. (2019) Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism 92, pages 108-120.
Crossref
Crossref
Huda Alalami, Thozhukat Sathyapalan & Stephen L. Atkin. (2018) Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism 10, pages 204201881880567.
Crossref
Crossref
Chau T. Tay, Anju E. Joham, Danielle S. Hiam, Moustafa A. Gadalla, Jyotsna Pundir, Shakila Thangaratinam, Helena J. Teede & Lisa J. Moran. (2018) Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews. Clinical Endocrinology 89:5, pages 535-553.
Crossref
Crossref
Cristina Bianchi, Giuseppe Daniele, Angela Dardano & Stefano Del Prato. 2018. Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
527
569
.
Cristina Bianchi, Giuseppe Daniele, Angela Dardano & Stefano Del Prato. 2018. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
1
44
.
Yuanyuan Wu, Pengfen Li, Dan Zhang & Yingpu Sun. (2017) Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK/PI3K/JNK pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Kun-lin Li, Li Li, Peng Zhang, Jun Kang, Yu-bo Wang, Heng-yi Chen & Yong He. (2017) A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non–Small-cell Lung Cancer. Clinical Lung Cancer 18:3, pages 340-343.
Crossref
Crossref
Kunal Maniar, Amal Moideen, Ankur Mittal, Amol Patil, Amitava Chakrabarti & Dibyajyoti Banerjee. (2017) A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?. Pharmacological Research 117, pages 103-128.
Crossref
Crossref
Ahmed S. El-Halwagy, Adel A. Al-Gergawy, Engy S. Eleslam & Enaam S. Abd Elbar. (2017) Clinical and Biochemical Changes in Polycystic Ovarian Syndrome Patients in Response to 3 Different Oral Hypoglycemic Drugs: A Double Blind Randomized Controlled Study. Open Journal of Obstetrics and Gynecology 07:01, pages 117-128.
Crossref
Crossref
Ricardo Azziz, Enrico Carmina, ZiJiang Chen, Andrea Dunaif, Joop S. E. Laven, Richard S. Legro, Daria Lizneva, Barbara Natterson-Horowtiz, Helena J. Teede & Bulent O. Yildiz. (2016) Polycystic ovary syndrome. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
E.J. Zuuren & Z. Fedorowicz. (2016)
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including
GRADE
assessments
. British Journal of Dermatology 175:1, pages 45-61.
Crossref
Crossref
E. N. Andreeva, O. R. Grigoryan & G. A. Melnichenko. (2016) The influence combination of sibutramine/metformin hydrochloride on Anti-Müllerian hormone level in women with metabolic syndrome and polycystic ovary syndrome. Problemy reproduktsii 22:1, pages 35.
Crossref
Crossref
Neil F. Goodman, Rhoda H. Cobin, Walter Futterweit, Jennifer S. Glueck, Richard S. Legro & Enrico Carmina. (2015) American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2. Endocrine Practice 21:12, pages 1415-1426.
Crossref
Crossref
Oded Stempa. (2015) Pioglitazone: lessons and learnings 15 years since launch and beyond. Diabetes Management 5:6, pages 415-429.
Crossref
Crossref
Negar Naderpoor, Soulmaz Shorakae, Barbora de Courten, Marie L. Misso, Lisa J Moran & Helena J. Teede. (2015) Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Human Reproduction Update 21:5, pages 560-574.
Crossref
Crossref
Esther J van Zuuren, Zbys Fedorowicz, Ben Carter & Nikolaos Pandis. (2015) Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database of Systematic Reviews 2017:5.
Crossref
Crossref
Sunder Mudaliar & Robert R. Henry. 2015. International Textbook of Diabetes Mellitus. International Textbook of Diabetes Mellitus
657
672
.
Eugenia Resmini & Mónica González Fernández. 2015. PanVascular Medicine. PanVascular Medicine
4635
4640
.
Najwa Somani & Diane Turvy. (2014) Hirsutism: An Evidence-Based Treatment Update. American Journal of Clinical Dermatology 15:3, pages 247-266.
Crossref
Crossref
Gaspare Stabile, Irene Borrielli, Alfredo Carducci Artenisio, Lucia Maria Bruno, Salvatore Benvenga, Loretta Giunta, Antonio La Marca, Annibale Volpe & Alfonsa Pizzo. (2014) Effects of the Insulin Sensitizer Pioglitazone on Menstrual Irregularity, Insulin Resistance and Hyperandrogenism in Young Women with Polycystic Ovary Syndrome. Journal of Pediatric and Adolescent Gynecology 27:3, pages 177-182.
Crossref
Crossref
Joselyn Rojas, Mervin Chávez-Castillo & Valmore Bermúdez. (2014) The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus. International Journal of Reproductive Medicine 2014, pages 1-14.
Crossref
Crossref
Hamidreza Mani, Kamlesh Khunti, Miles Levy & Melanie J Davies. (2013) Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention. Diabetes Management 3:6, pages 467-480.
Crossref
Crossref
Theodore P. Ciaraldi, Vanita Aroda, Sunder R. Mudaliar & Robert R. Henry. (2013) Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: Effects of pioglitazone and metformin treatment. Metabolism 62:11, pages 1587-1596.
Crossref
Crossref
Wessam Magdi Abuelghar, Osama Saleh Elkady & Ahmed Abdelmohsen Khamees. (2013) Clomiphene citrate alone, in combination with metformin or in combination with pioglitazone as first line therapy in induction of ovulation in infertile women with polycystic ovary syndrome, a randomized controlled trial. Middle East Fertility Society Journal 18:3, pages 135-141.
Crossref
Crossref
Ladan Kashani, Targol Omidvar, Behnoud Farazmand, Amirhossein Modabbernia, Fatemeh Ramzanzadeh, Ensiyeh Shahrokh Tehraninejad, Mandana Ashrafi, Mina Tabrizi & Shahin Akhondzadeh. (2013) Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression. Psychoneuroendocrinology 38:6, pages 767-776.
Crossref
Crossref
Hanford Yau, Kathya Rivera, Romina Lomonaco & Kenneth Cusi. (2013) The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus. Current Diabetes Reports 13:3, pages 329-341.
Crossref
Crossref
Anindya Dasgupta, Aparna Khan, Ushasi Banerjee, Mrinalkanti Ghosh, Mrinal Pal, Kanika M. Chowdhury & Sayantan Dasgupta. (2012) Predictors of Insulin Resistance and Metabolic Complications in Polycystic Ovarian Syndrome in an Eastern Indian Population. Indian Journal of Clinical Biochemistry 28:2, pages 169-176.
Crossref
Crossref
Jennifer H. Gunter, Phoebe L. Sarkar, Amy A. Lubik & Colleen C. Nelson. (2013) New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication. International Journal of Cell Biology 2013, pages 1-13.
Crossref
Crossref
Martina Düfer, Katja Noack, Armin Edalat, Peter Krippeit-Drews & Gisela Drews. (2013)
Glitazones Exert Multiple Effects on
β
-Cell Stimulus-Secretion Coupling
. Molecular Pharmacology 83:1, pages 51-60.
Crossref
Crossref
Eugenia Resmini & Mónica González Fernández. 2013. PanVascular Medicine. PanVascular Medicine
1
8
.